Introduction
Maintenance of the intracellular ionic environment is necessary for homeostasis in living cells. The regulation of ion concentrations in cytoplasm is achieved through the balancing activities of ion pumps and transporters that are localized in the plasma membranes [1] . The carrier-mediated exchange of sodium for protons across biological membranes has been demonstrated in organisms from simple prokaryotes to more complex eukaryotes of the plant, fungi and animal kingdoms. This cation flux, conducted by a family of polytopic membrane proteins called Na + /H + antiporters or exchangers, are classified as secondary active transporters [2, 3] . The driving force for the exchange is not coupled directly to the hydrolysis of ATP, but is derived from the electrochemical gradient established for one of the solutes that drives the counter transport of the other [3] .
The family of Na + /H + exchangers [NHEs] , exhibits different tissue and cellular localization patterns and mediates a wide variety of physiological functions. Ten isoforms [NHE1-NHE10] have been identified within the mammalian NHE family [1, 3, 4] . The isoforms share approx 25%-70% amino acid identity, with calculated relative molecular masses ranging from approx. 74000 to 93000 Daltons [3, 5] . Hydropathy analysis of the exchanger predicts that they have similar membrane topologies with an N-terminal membrane domain consisting of 12 transmembrane [TM] segments followed by a hydrophilic C terminus that is oriented towards the cytoplasm [4] .
The biochemical analyses of plasmalemmal NHEs suggest that they assemble and function as homodimers [6, 7] , a structure that is similar to the recently discovered crystal structure of the bacterial Escherichia coli Na + /H + antiporter NhaA. However, unlike NhaA that operates as AN electrogenic transporter, the mammalian NHEs are electroneutral antiporters that exchange 1 H + per 1 Na + [8] . From the ten isoforms cloned, five different plasmalemmal-type NHEs, NHE1-5 have been identified. The NHE1 isoform is the 'housekeeping' isoform of the exchanger, and it is ubiquitously expressed in the plasma membrane of virtually all tissues. Although NHE2-NHE5 isoforms are also localized to the plasma membrane, they have a limited tissue distribution.
NHE2 is expressed in the apical membrane of the medullary thick ascending limb [MTAL] cells and in the apical membrane of intestinal epithelial cells [9, 10] . NHE3 is expressed at high levels in kidney apical membranes from proximal tubule [PT] and from TAL cells. Significant levels of NHE3 are also present in colon and small intestine cells [11, 12] . NHE4 is most abundant in the stomach, followed by intermediate levels in the small intestine and the colon and lesser amounts in renal TAL cells, in the brain, uterus and in skeletal muscles [10, 13] .
NHE5 has been shown to be expressed in the brain. It may also be localized at low levels in other non-epithelial tissues, as in the spleen, testis and skeletal muscles [14, 15] . NHE6-NHE9, ubiquitously expressed and localized in intracellular compartments are involved in the regulation of luminal pH and the cation concentration of the intracellular compartments [1, 16] . NHE6 is an endosomal Na + /H + exchanger that may regulate intravesicular pH and cell volume contributing to lysosomal biogenesis [17] . The NHE7 isoform is found predominantly in the trans-Golgi network and differs from the other NHE isoforms because of the influx of either Na + or K + in exchange for H + [17] . The transcript of NHE8 is relatively high in skeletal muscles and the kidney where it is abundant in proximal tubules in the outer medulla and cortex of the kidney as is reported by Goyal et al. [18] . NHE9 isoform is localized to late recycling endosomes [1, 4] . The recently identified NHE10 is expressed in osteoclasts. The exchanger is necessary for the differentiation and survival of these cells [19] .
The present review will focus only on the functionality, regulation, and the role of the ubiquitous plasma membrane NHE isoform, NHE1. We describe evidence concerning the non-transport functions of the exchanger by analysing how structural functions join together with ion translocation to regulate renal epithelial cell survival.
Structural and functional analysis of the Na + /H + exchanger
The NHE1 isoform is the most studied of the NHE family. The NHE1 gene [SLC9A1] maps to chromosome 1p36.11 in humans. Human NHE1 is an 815-amino acid glycoprotein with residues between 1-500, which contains three consensus N-glycosylation sites, and which translocation domain extrudes 1 intracellular proton in exchange for 1 extracellular sodium ion, protecting the cell from acidification and regulating intracellular pH (pHi) [21] . This is followed by hydrophilic, carboxyl-terminal cytosolic domain that regulates the membrane domain, and much of the regulation is by phosphorylation occurring in the distal 178 amino acids of the cytosolic domain.
Intracellular acidosis is the major stimulus involved in the regulation of NHE1 activity. NHE1 is essentially silent in most cell types at normal pHi, although it is quickly activated due to the decrease in pHi [22, 23] . Studies have proposed that this regulation occurs because of the interaction of H + with an allosteric modifier site ("pH i sensor") within the transport [24, 25] .
NHE1 is known to require cellular ATP. The depletion of ATP, induced by treatment with metabolic inhibitors, abrogates the exchanger activity [26] even though there is no requirement for any energy input from ATP hydrolysis. As NHE1 is partially phosphorylated under basal conditions [27] , it is possible that the NHE1 requirement for ATP is linked to the phosphorylation of the exchanger. However, some studies concluded that phosphorylation of NHE1 may not be involved in any ATP-dependent activation of NHE1 because ATP depletion does not change the phosphorylation state [28, 29] . A possible mechanism is that NHE1 may be directly modulated by ATP [30] . One investigation by Shimada-Shimizu et al shows that ATP directly binds to the proximal cytoplasmic region (Gly542-Pro598), which is critical for the ATP-dependent regulation of NHE1 [31] .These findings suggest that NHE1 is an ATPbinding transporter. In addition to the intracellular proton response, NHE1 activity is also regulated by the phosphorylation of key amino acids in its (300 amino acids) COOH -(C) terminal cytoplasmic domain and by interactions of the C-terminal tail with intracellular proteins and lipids [ Fig. 1A and B] .
Regulation of NHE1 at the molecular level has been studied in a variety of cell types. NHE1 regulators modify transport activity by altering the affinity for intracellular H + . These regulators of NHE1 are activated or controlled by extracellular growth factors, hormones and other agonists like Angiotensin II, serum, thrombin and the epidermal growth factor [22, 25] .
Physiological Functions of NHE1
NHE1 is often referred to as a housekeeping protein because one major function is to maintain intracellular pH and volume.
NHE1 in the regulation of intracellular pH
NHE1 activation results in electroneutral (1:1 stoichiometry) Na + /H + exchange Intracellular acidification allosterically increases the activity of NHE which results in a rapid increase in pHi and because of this the exchanger protects cells from intracellular acidification. Mutant cell lines that are devoid of this exchange activity are extremely sensitive to acidosis [32, 33] . NHE1 also serves as a major Na + entry pathway in many cell types, and therefore regulates both sodium fluxes and cell volume after osmotic shrinkage [25, 34] .
The volume-or osmolarity-sensitive site (s) within NHE1 exist between the NH2-terminus and residue 566. The mechanism by which NHE1 regulates cell volume remains elusive [35] .
NHE1 in the regulation of cell volume
NHE1 often mediates the direct influx of the major extracellular cation sodium through the intracellular space along with the coupled subsequent osmotic movement of water. This process, known as regulatory volume increase [RVI], serves to counteract decreased cell volume.
Cell shrinkage results from the exposure to a hypertonic extracellular milieu. This event is then counterbalanced by the influx of sodium and chloride and the accompanying osmotic driven influx of water which generates a compensatory cell swelling. Throughout the duration of the RVI, sodium is transported into the cell in exchange for protons mediated by NHE1 [36] . The net gain of sodium with negligible change in proton concentration results in a net osmotic gain due to the replacement of the extruded protons through a dissociation of cytosolic weak acids [37] . The entrance of water through water channels, such as aquaporin 1 [AQP1] comes after the influx of salt.
The intracellular concentration of bicarbonate also increases because the membrane is freely permeable to carbon dioxide as the pH rises. This growth in bicarbonate concentration drives chloride into the cell via electroneutral anion exchanger Cl − /HCO3 − (AE). This event then leads to a combined gain of sodium and chloride all the while extruding protons and bicarbonate, in sequence [38] . The translocated proton and bicarbonate recombine in the extracellular space to produce water and carbon dioxide. This CO2 can re-enter and diffuse into the cell and is thus osmotically not relevant [38] .
Considering this, NHE1 is the primary mechanism driving RVI in many cell types. This statement has been confirmed by deletion experiments. It has become clear that mutant cells lacking NHE1 fail to regain volume after imposed shrinkage [39] .
In addition to its roles in regulating cellular pH and volume, NHE also initiates shifts in pHi that stimulate changes in the growth and functions of the cells [36, 40] . It is well established that activation of the Na-H exchanger NHE1 and increases in intracellular pH (pH i ) are early responses to mitogens and have permissive effects in promoting cell proliferation [41] . In this regard, Putney et al showed that NHE1 activity and pH i regulate the timing of G 2 /M entry and transition and that efficient timing requires a pH i of greater than 7.30 which is promoted by NHE1 activity [42] .
The exchanger also plays a role in either promoting or inhibiting programmed cell death, a function that changes depending on cell type [43, 44] .
NHE1 regulation mediated by proteins, cofactors, protein kinases

Regulation by Phosphorylation
The distal region of the C-terminal tail of NHE1, which it is comprised of aminoacids ∼700-815, contains a number of serine and threonine residues. These are phosphorylated by protein kinases in response to sustained acidosis and /or to hormone and growth-factor stimulation [23, 27, 45] .
The phosphorylation of residues in this region moves the set point of the exchanger by modifying transport activity. This happens because of the change in affinity for intracellular H + , which causes the exchange to be more active at greater alkaline pHi values. Several protein kinases involved in the regulation of NHE1 are known to phosphorylate specific amino acids within the cytosolic domain. Therefore, p160ROCK, a serine / threonine protein kinase, is a direct RhoA target, which mediates the Rho A-induced assembly of focal adhesions and stress fibers. p160 ROCK has been identified as an direct upstream activator of NHE1, which suggests that this kinase induces NHE1 activity and phosphorylation that are necessary for actin stress fiber assemblies [46] . Moreover, the activation of NHE1 is necessary for the RhoA-induced reorganization of the actin cytoskeleton [47] . This occurs as a consequence of the link between NHE1 and the actin binding proteins ezrin, radixin, and moesin [ERM] at residues 553-564 in the C-terminal tail of NHE1 [48] .
Regulation of the cell cytoskeleton may be important for apoptosis [49] where cell adhesion may play a critical role [50] . We have previously shown RhoA pathway involvement through its translocation and its further membrane-associated GTP-bound activation in the regulation of apoptosis in 14 day obstructed cortex rat kidney epithelial cells [51] . NHE1 is regulated by MAPKs under certain conditions, however, a number of studies have shown a central role for NHE1 upstream of MAPKs after a variety of stimuli [52] .
MAPKs and the regulation of membrane transport proteins
MAPKs are important regulators of many membrane transport proteins at gene transcription level, via their downstream effectors [53] . Moreover, these signaling pathways and/or their downstream effectors also posttranscriptionally regulate the activity of multiple transporters. This happens either directly by phosphorylation of the transporter, or indirectly by phosphorylation of regulatory enzymes [54] [55] [56] .
The direct involvement of phosphorylation in the regulation of NHE1 activity by MAPKs has been previously reported [57] . Takahashi [59] .
Shrinkage-induced NHE1 activation is dependent on PKC and p38 MAPK, but not on ERK1/2. NHE function under both iso-and hypertonic conditions increases with the inhibition of serine/ threonine phosphatases, and this effect appears to be counteracted by the inhibition of PKC [60] .
The protein kinase C [PKC] has been the most extensively investigated kinase, which is involved in this mechanism. The activation of PKC, either directly by phorbol esters [61] or indirectly via cell surface receptors [62] , leads to an increase of the exchanger in a variety of cell types whereas putative PKC inhibitors block such effects [62, 63] .
It has also been proposed that NHE1 is directly phosphorylated by p38 MAPK [64] . Alkalinization requires the stress p38 mitogen-activated protein kinase [MAPK] . In relation to this evidence, inhibition of p38 MAPK activity with pharmacological inhibitors or the expression of a dominant negative kinase prevents this alkalinization. Activated p38 MAPK is directly phosphorylated at the C terminus of NHE1 within a 40-aminoacid region.
A substantial body of studies indicate that NHE1 can regulate the activity of ERK1/2, JNK, and p38 MAPK. Notwithstanding, the effects of NHE1 on MAPK activity are highly contextual and cell type-specific.
Rentsch and al. have worked on fibroblasts demonstrating that ischemia anoxia is associated with an increased activity of NHE1 and also with p38 MAPK but at a slower rate. ERK 1/2 was not affected [65] . In Ehrlich Lettre Ascites cells (ELA cells) osmotic cell shrinkage upregulates NHE1 and negatively regulates ERK1/2 activity [66] . The effect of NHE1 on MAPK activity has also been observed in epithelial cells.
The rapid activation of NHE1 by Aldosterone at nanomolar concentrations, a nongenomic mechanism, involves ERK1/2. Consequently, in Madin-Darby canine kidney [MDCK] cells, Aldosterone modulates Na + /H + exchange by means of ERK1/2 [67] . Therefore we can say that in certain cell types, the MAPK cascade may represent an additional pathway by mediating the rapid Aldosterone effects.
It has been recently demonstrated that acute sustained intracellular acidosis [SIA] in MDCK cells occurs through an ERK-dependent pathway affecting the phosphorylation of the amino acids in the cytosolic regulatory tail of NHE. It is interesting to note that this was blocked by treatment with the MEK inhibitor U0126 [68] .
While under several conditions, NHE1 is regulated by MAPKs, recent studies have, conversely, implicated NHE1 in the regulation of MAPK activity.
The precise pathways leading from NHE1 to MAPK regulation need to be determined. These studies should look at the roles of the transported ions in relation to those events involving the conformational coupling of NHE1 to enzymes or cytoskeletal elements [52, 69] .
Regulatory proteins and cofactors
Much of the hormonal regulation of NHE1 is not due just to phosphorylation, but is also mediated by several regulatory proteins and cofactors. These include calcium binding proteins that associate with the cytosolic regulatory tail. Calmodulin [CaM] likewise binds to a high-and low-affinity site which is located between amino acids 636 and 700 and blocks an auto-inhibitory site, thereby activating NHE1 as has been studied by Fliegel et al. [22] . The calcineurin homologous protein [CHP] group of regulatory calcium-binding proteins is also bound to the cytosolic regulatory tail. CHP1 and CHP2 bind to NHE1 in the amino acid regions of 518 to 537 [22] (Figure1B) .
Recent results have demonstrated that CHP1 binding has two functions. First, it is important for antiporter activity; and, second, for the stabilization of NHE1 because of its ability to mask a degradation signal [70] . In conclusion, increased stability and the translocation of NHE1 is mediated by the direct binding of CHP1.
Furthermore, NHE1 has many different binding partners. This suggests that NHE1 without binding to CHP1 proteins may have an unstable conformation even if they can localize to the plasma membrane [71] . CHP2 is highly expressed in tumor cells; it is protective against serum deprivation-induced cell death by increasing pHi [71] , and may play a role in the enhanced proliferation of tumor cells [72] .
CHP-related protein tescalcin or CHIP3 [binding site uncertain] is thought to promote maturation and cell surface stability of the NHE1C-terminus of the Na + /H + exchanger. This protein exists primarily as a monomeric protein that binds regulatory tescalcin and can change conformation depending on pH and calcium [73] .
The signaling molecule phosphatidylinositol 4,5-biphosphate [PIP2] binds to NHE1 at two putative PIP2-binding motifs within the C-terminal domain at residues 513-520 and 556-564 ( Figure 1B) . The binding of PIP2 to NHE1 is required for the optimal activity of the exchanger, and this interaction at least partially, accounts for the ATP dependence of NHE1. It has been demonstrated that PIP2 depletion leads to an ATP-dependent inhibition of NHE1 [74] . In addition, the actin-binding ERM [i.e., ezrin, radixin, and moesin] proteins bind to NHE1 between aminoacids 552 and 560, and they manage the proper localization of NHE1 to the plasma membrane as well as the maintenance of cell shape [75] . As has been demonstrated by Schelling et al., PI(4,5) P2 target NHE1 and ERM to the same plasma membrane domain. NHE1-ERM interaction leads to the formation of a signaling complex that includes phosphatidylinositol 3-kinase (PI3K) and, ultimately, the prosurvival kinase Akt. This complex phosphorylates multiple substrates, resulting in apoptosis inhibition in renal tubular epithelial cells [44] .
Carbonic Anhydrase II [CAII] , an enzyme that catalyzes the production of HCO 3 _ and H + from the hydration of CO2, binds to NHE1 at amino acid residues [790 to 802] increasing the activity of the exchanger [76] . The 14-3-3-adaptor protein only binds to NHE1 when it is phosphorylated at S703, which results in NHE1 activation that protects S703 from dephosphorylation. In this way, the functional binding of 14-3-3 to the exchanger is necessary for the activation of NHE1 by serum [77] . In addition, heat shock protein 70 [Hsp70] is linked to NHE1 and may play a role in the protein folding [78] . ] ranges from 140 mmol/L in the renal cortex to as high as 300 mmol/L in the deep medulla [79, 80] . Newly synthesized NHE1 is localized in both apical and basolateral plasma membranes in polarized epithelial cells. However, mature NHE1 is localized almost exclusively in the basolateral membrane.
Na
NHE1 has been shown to be expressed at the basolateral membrane of all nephron segments in the kidney, with the exception of the macula densa and cortical collecting duct intercalated cells [80, 81] .
NHE3 has been observed in the apical surface in the proximal tubules as in the loop of Henle. Proximal tubule cells secrete H + from the cytosol across the microvillus apical membrane into the lumen via NHE3 and the vacuolar-type H + -ATPase [82] . The secreted H + and luminal HCO3 -is converted to CO2 and H 2 O by carbonic anhydrase IV, an apical membrane-associated carbonic anhydrase [CA] [83] . The CO 2 and H 2 O rapidly reenter the cell across the apical membrane.
In the cytosol, CO 2 and H2O are converted back into HCO 3 -and H + by CA II, the HCO3 These findings have been postulated as regulatory cross-talk between basolateral NHE1 and apical NHE3 because pharmacologic inhibition of basolateral NHE1 downregulates apical NHE3 activity [87] .
In the TAL a significant amount of the luminal ammonium is reabsorbed, shunting the distal tubule, and it is secreted again in the collecting duct. NHE1 and/or NHE4 may play a role in the transepithelial transport of ammonium by mediating NH 4 + extrusion at the basolateral membrane. Apical membrane NHE3 and NHE2 are responsible for the absorption of most of the remaining luminal bicarbonate following the same mechanism as in the proximal tubule [79, 85] .
Involvement of NHE1 in epithelial renal cell survival
NHE1, in addition to its effect on the regulation of cellular pH and volume, plays a role in either promoting or inhibiting programmed cell death depending on the cell type. The destruction of renal tubular cells [RTC] by apoptosis [92, 93] leads to tubular atrophy, a hallmark of chronic renal diseases [94] . Significant epithelial cell apoptosis within the proximal tubule has been demonstrated in progressive renal disease [95] .
After exposure to an injury stimulus, epithelium-derived cells are relatively resistant to apoptosis due to their great capacity to expand their intracellular volume through RVI which differs from neuronal cells and lymphocytes [96] .
RVI is carried out by NHE1 activation, and depending on the cell type, by the AE2 isoform of the Cl − /HCO 3 − exchanger and /or the Na
− symporter [97, 98] . If these RVI-dependent transporters are robustly activated after the initiation of an apoptotic stimulus, the restoration of intracellular volume may stop programmed cell death [99] . On the contrary, for a cell to undergo apoptosis, RVI must be overcome or inhibited [98, 99] .
Neither AE2 nor the types 1 or 2 bumetanide-sensitive cotransporter [BSC-1 or BSC-2, respectively] isoforms of the Na
− symporter are expressed in proximal tubule cells [100, 101] . As long as NHE1 is ubiquitously expressed within the proximal tubule, the exchanger is critical for RTC survival by promoting resistance to apoptotic cell shrinkage.
In animal models of progressive renal disease, the proximal tubule segment triggers abundant cell apoptosis [92, 99] . This process is characterized by cell volume shrinkage and cytosol acidification leading to the activation of pro-apoptotic caspases [102] and conformational changes in Bax [103] , which are consistent with a pH threshold for triggering cell death pathways [92, 99] .
Schelling et al investigated whether RTC apoptosis requires caspase cleavage of NHE1. Staurosporine and hypertonic NaCl-induced RTC cell death was associated with cell shrinkage and diminished cytosolic pH, and apoptosis was enhanced by amiloride analogs, suggesting NHE1 activity opposes to cell death [104] .
Under normal circumstances, the NHE1 "housekeeping" activity is not required. However, the exchanger plays an important role in the condition of cellular stress. Experimental studies have been performed on mice targeting NHE1 gene deletion or a spontaneous point mutation that introduces a premature stop codon. This results in a truncation between the 11th and 12th NHE1 transmembrane domains and the loss of NHE1 function (Swemice) [105] . Swemice treated with the podocyte toxin Adriamycin, developed increased cortical tubular epithelial cell apoptosis when compared to wild-type controls [104] .
In addition, streptozotocin induced diabetes in NHE1-deficient swe/swe mice, which gives rise to greater azotemia, albuminuria and tubulointerstitial pathologies when compared to wild-type control animals. Increased RTC apoptosis was noted in these mice suggesting that the loss of NHE1 function leads to tubular atrophy, an indicator of kidney disease [106] .
In the context of these findings, Schelling et al proposed that the combination of the loss of NHE1 function and glomerular injury from Adriamycin or Streptozotocin was sufficient for overcoming the protective genetic background effects [104, 106] .
We demonstrated that tubular epithelial cell apoptosis is associated with decreased NHE1 expression in a neonatal rat model of ureteral obstruction [107] . After 14 days of ureteral obstruction, there were consistently more apoptotic cells in cortical ducts [CD] than in proximal tubules [PT] , which is associated with a lower expression of NHE1 at the mRNA and protein levels. There was an increased expression of the Bax/BcL2 ratio, which is linked to decreased pro-caspase-3 protein levels and with increased caspase-3 activation. We also showed that inhibiting NHE1 by increasing doses of EIPA induced epithelial cell apoptosis and increased caspase-3 activity in a dose-dependent manner in neonatal obstruction.Therefore, the decreased NHE1 expression could be a signal-transduction event participating in the induction of the apoptosis through the regulation of the BcL-2 gene family and the activation of caspase-3 [107] .
In another study, we found that the convergence of two independent signal pathways, the RhoA GTPase and pERK along with the concurrent inhibition of JNK MAP kinase were required for the apoptotic response in 14 day kidney cortex obstructed tubular epithelial cells [51] .
In recent studies, we reproduced mechanical proximal tubule cell deformation by exposing HK-2 cells to cyclic mechanical stretch. In a time-dependent manner, as mechanical deformation increased, NHE1 protein expression gradually decreased reaching the maximum decrease at 180 min of cyclic stretch. This is in accordance with the highest activation of caspase 3 and apoptosis induction.
By silencing the exchanger by NHE1-siRNA, we further confirmed the direct participation of NHE1 in cell survival due to a decreased Bcl2 and increased caspase 3 protein expressions. Moreover, after NHE1 knockdown and subsequent mechanical deformation in HK-2; apoptotic cells exceeded the values observed in non-targeted NHE1 stretched cells as well as those values recorded from EIPA treated stretched cells [108] .
NHE1 is dependent on protein scaffolding even though it functions as a pHi regulator. We showed an early and progressive activation of RhoA in HK-2 cells exposed to cyclic stretch. Higher membrane bound RhoA precedes NHE1 downregulation and reaches its maximal activation state at 180 minutes during mechanical deformation, in agreement to NHE1 downregulation and apoptosis induction [108] .
In HK-2 stretched cells, early ERK1/2 activation with an intensive phosphorylation demonstrates a later decrease of ERK1/2 at 180 min of cyclic stretch. Contrarily, p38 MAPKinase reaches its maximal phosphorylation state at 180 min of mechanical stretch [108] . We observed an increase in NHE1 protein expression without caspase 3 activation after p38 inhibition. On the other hand, ERK 1/2 inhibition leads to decreased NHE1 expression and caspase 3 activation.
The manipulation of MAPKs activation also affects NHE1 function, showing diminished pHi recovery after ERK ½ inhibition and NHE1 activity similar to control when HK2 cells were incubated with the p38 inhibitor.
Taken together, our data obtained from human proximal tubule cells suggest that RhoA signaling pathway activation following mechanical stretch induces ERK 1/2 inhibition and p38 activation. This leads to the downregulation of NHE1 expression and activity, which consequently triggers caspase 3 activation and apoptosis induction [108] , see Fig 2. Experiments in which NHE1-null proximal tubule cells demonstrate an enhanced sensitivity to multiple apoptotic stimuli when compared with wild-type cells is evidence for a cytoprotective role of the exchanger [109] . 
Conclusion
These data indicate that apoptotic stress triggers early NHE1-dependent defence mechanisms against cell volume reduction and intracellular acidification. However, this survival NHE1 effect can be overcome by overwhelmingly sustained apoptotic stimuli allowing programmed cell death.
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